{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:04:45Z","timestamp":1790197485342,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA056254"],"award-info":[{"award-number":["DA056254"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA039997"],"award-info":[{"award-number":["DA039997"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM140223"],"award-info":[{"award-number":["T32 GM140223"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molpha.2026.100152","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:31:54Z","timestamp":1787614314000},"page":"100152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High potency \u03bc-opioid receptor agonists engage sodium-bound receptor states"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8076-0563","authenticated-orcid":false,"given":"Alexander J.","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0714-4712","authenticated-orcid":false,"given":"Nicholas W.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7010-089X","authenticated-orcid":false,"given":"Jorge A.","family":"I\u00f1iguez-Lluh\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry I.","family":"Mosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-8316","authenticated-orcid":false,"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2026.100152_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmbts.2018.08.001","article-title":"Analysis of biased agonism","volume":"160","author":"Ehlert","year":"2018","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/mol.117.108787","article-title":"A scale of agonism and allosteric modulation for assessment of selectivity, bias, and receptor mutation","volume":"92","author":"Kenakin","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tips.2011.01.002","article-title":"Analytical pharmacology: the impact of numbers on pharmacology","volume":"32","author":"Kenakin","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molpha.2026.100152_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10842","article-title":"The role of kinetic context in apparent biased agonism at GPCRs","volume":"7","author":"Klein Herenbrink","year":"2016","journal-title":"Nat Commun"},{"issue":"4119","key":"10.1016\/j.molpha.2026.100152_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","article-title":"Opiate agonists and antagonists discriminated by receptor binding in brain","volume":"182","author":"Pert","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molpha.2026.100152_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0026-895X(25)10340-4","article-title":"Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes","volume":"30","author":"Werling","year":"1986","journal-title":"Mol Pharmacol"},{"issue":"51","key":"10.1016\/j.molpha.2026.100152_bib8","doi-asserted-by":"crossref","first-page":"18369","DOI":"10.1073\/pnas.1415013111","article-title":"Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor","volume":"111","author":"Livingston","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.molpha.2026.100152_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem Sci"},{"issue":"6091","key":"10.1016\/j.molpha.2026.100152_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.1219218","article-title":"Structural basis for allosteric regulation of GPCRs by sodium ions","volume":"337","author":"Liu","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molpha.2026.100152_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.str.2017.12.013","article-title":"Structural connection between activation microswitch and allosteric sodium site in GPCR signaling","volume":"26","author":"White","year":"2018","journal-title":"Structure"},{"issue":"3","key":"10.1016\/j.molpha.2026.100152_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1471-4159.1980.tb11184.x","article-title":"Differential regulation by guanine nucleotides or opiate agonist and antagonist receptor interactions","volume":"34","author":"Childers","year":"1980","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.molpha.2026.100152_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(99)00460-4","article-title":"Differential binding properties of oripavines at cloned mu- and delta-opioid receptors","volume":"378","author":"Lee","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"7945","key":"10.1016\/j.molpha.2026.100152_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","article-title":"Structure-based design of bitopic ligands for the \u03bc-opioid receptor","volume":"613","author":"Faouzi","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molpha.2026.100152_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/acschemneuro.5b00100","article-title":"Asymmetric synthesis and in vitro and in vivo activity of tetrahydroquinolines featuring a diverse set of polar substitutions at the 6 position as mixed-efficacy \u03bc opioid receptor\/\u03b4 opioid receptor ligands","volume":"6","author":"Bender","year":"2015","journal-title":"ACS Chem Neurosci"},{"issue":"22","key":"10.1016\/j.molpha.2026.100152_bib16","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1021\/acs.jmedchem.5b01270","article-title":"Further optimization and evaluation of bioavailable, mixed-efficacy \u03bc-opioid receptor (MOR) agonists\/\u03b4-opioid receptor (DOR) antagonists: balancing MOR and DOR affinities","volume":"58","author":"Harland","year":"2015","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.molpha.2026.100152_bib17","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1021\/acs.jmedchem.6b00308","article-title":"Effects of N-substitutions on the tetrahydroquinoline (THQ) core of mixed-efficacy \u03bc-opioid receptor (MOR)\/ \u03b4-opioid receptor (DOR) ligands","volume":"59","author":"Harland","year":"2016","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.molpha.2026.100152_bib18","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/acschemneuro.8b00139","article-title":"Synthesis and pharmacological evaluation of novel C-8 substituted tetrahydroquinolines as balanced-affinity mu\/delta opioid ligands for the treatment of pain","volume":"9","author":"Nastase","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"23","key":"10.1016\/j.molpha.2026.100152_bib19","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.3390\/molecules24234302","article-title":"Structure-activity relationships of 7-substituted dimethyltyrosine-tetrahydroisoquinoline opioid peptidomimetics","volume":"24","author":"Montgomery","year":"2019","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.molpha.2026.100152_bib20","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acschemneuro.9b00250","article-title":"Novel dimethyltyrosine-tetrahydroisoquinoline peptidomimetics with aromatic tetrahydroisoquinoline substitutions show in vitro kappa and mu opioid receptor agonism","volume":"10","author":"Montgomery","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"10.1016\/j.molpha.2026.100152_bib21","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/acs.jmedchem.9b00378","article-title":"Dual pharmacophores explored via structure-activity relationship (SAR) matrix: insights into potent, bifunctional opioid ligand design","volume":"62","author":"Nastase","year":"2019","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.molpha.2026.100152_bib22","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acschemneuro.4c00203","article-title":"Structure-activity relationships of the fentanyl scaffold: identification of antagonists as potential opioid overdose reversal agents","volume":"15","author":"Anand","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2026.100152_bib23","article-title":"Boltz-2: towards accurate and efficient binding affinity prediction","author":"Passaro","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.molpha.2026.100152_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Methods"},{"issue":"7820","key":"10.1016\/j.molpha.2026.100152_bib28","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1038\/s41586-020-2542-z","article-title":"Author correction: structural insights into \u03bc-opioid receptor activation","volume":"584","author":"Huang","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2026.100152_bib29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats","volume":"316","author":"Peckham","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.molpha.2026.100152_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/mol.51.1.87","article-title":"\u03bc-Opioid receptor-stimulated guanosine-5\u2032-O-(\u03b3-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy","volume":"51","author":"Selley","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100152_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/syn.890210109","article-title":"Ligand selectivity of cloned human and rat opioid mu receptors","volume":"21","author":"Rothman","year":"1995","journal-title":"Synapse"},{"issue":"23","key":"10.1016\/j.molpha.2026.100152_bib32","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.molpha.2026.100152_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41422-025-01191-8","article-title":"The molecular basis of \u03bc-opioid receptor signaling plasticity","volume":"35","author":"Zhang","year":"2025","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","article-title":"Insights into distinct signaling profiles of the \u03bcOR activated by diverse agonists","volume":"19","author":"Qu","year":"2022","journal-title":"Nat Chem Biol"},{"issue":"8110","key":"10.1016\/j.molpha.2026.100152_bib35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41586-025-10056-4","article-title":"Non-equilibrium snapshots of ligand efficacy at the \u03bc-opioid receptor","volume":"652","author":"Robertson","year":"2025","journal-title":"Nature"},{"issue":"7711","key":"10.1016\/j.molpha.2026.100152_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the \u03bc-opioid receptor\u2013Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molpha.2026.100152_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.molpha.2026.100152_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea9832","article-title":"Structure-based design of an opioid receptor modulator for enhanced morphine analgesia","volume":"12","author":"Wang","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.molpha.2026.100152_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-76730-x","article-title":"Structure-guided allosteric modulation of the delta opioid receptor","author":"Mobbs","year":"2026","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0026-895X(25)13269-0","article-title":"BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells","volume":"44","author":"Childers","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100152_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-008-0637-6","article-title":"An ion-responsive motif in the second transmembrane segment of rhodopsin-like receptors","volume":"35","author":"Parker","year":"2008","journal-title":"Amino Acids"},{"issue":"31","key":"10.1016\/j.molpha.2026.100152_bib42","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1021\/bi5006915","article-title":"Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions","volume":"53","author":"Shang","year":"2014","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"10.1016\/j.molpha.2026.100152_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0014-5793(99)00316-6","article-title":"Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor","volume":"447","author":"Xu","year":"1999","journal-title":"FEBS Lett"},{"issue":"7487","key":"10.1016\/j.molpha.2026.100152_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature12944","article-title":"Molecular control of \u03b4-opioid receptor signalling","volume":"506","author":"Fenalti","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2026.100152_bib45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/mol.108.045054","article-title":"Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor","volume":"74","author":"Proulx","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100152_bib46","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0026-895X(25)09624-5","article-title":"Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding","volume":"50","author":"Barbhaiya","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100152_bib47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/mol.63.5.1021","article-title":"Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor","volume":"63","author":"Gao","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.molpha.2026.100152_bib48","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1073\/pnas.90.11.5133","article-title":"Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling","volume":"90","author":"Bihoreau","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.molpha.2026.100152_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092727","article-title":"The 2.1 \u00c5 resolution structure of cyanopindolol-bound \u03b21-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor","volume":"9","author":"Miller-Gallacher","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.molpha.2026.100152_bib50","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bph.17376","article-title":"Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the \u03bc-opioid receptor","volume":"182","author":"Alhosan","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2026.100152_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110601","article-title":"Comparison of ventilatory depression by carfentanil, fentanyl, and heroin, and reversal by opioid receptor antagonists in rats","volume":"279","author":"Flynn","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molpha.2026.100152_bib52","article-title":"Slow dissociation of nitazenes from the \u03bc -opioid receptor underlies the challenge of overdose reversal","author":"Clayton","year":"2026","journal-title":"bioRxiv"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:34:33Z","timestamp":1790195673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0026895X26000520"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100152","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High potency \u03bc-opioid receptor agonists engage sodium-bound receptor states","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100152"}}